|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,990.00 GBX | +0.79% |
|
+4.26% | -13.05% |
| 08-10 | Lupin Gets FDA Approval for Hyperkalemia Drug | DJ |
| 08-10 | The Stockholm stock exchange opened the week slightly lower, the OMXS30 index fell 0.2 percent | FW |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 211.55 | +31.78% | 22 | ||||||
| 1,292.53 | +9.01% | 27 | ||||||
| 272.5 | +5.12% | 22 | ||||||
| 274.36 | +11.51% | 28 | ||||||
| 370.31 | +0.82% | 18 | ||||||
| 154.05 | -1.22% | 21 | ||||||
| 378.31 | -7.94% | 29 | ||||||
| 314.24 | +3% | 24 | ||||||
| 157.41 | +18.16% | 27 | ||||||
| 28.64 | +7.04% | 26 | ||||||
| 66.21 | +2.3% | 24 | ||||||
| 559.28 | +12.74% | 25 | ||||||
| 21.51 | +9.73% | 20 | ||||||
| 94.45 | +25.42% | 23 | ||||||
| 9,513.33 | +38.74% | 15 | ||||||
| 56.81 | +14.04% | 18 | ||||||
| 6,387.69 | +15.3% | 16 | ||||||
| 80.33 | +47.08% | 15 | ||||||
| 4.196 | +13.6% | 17 | ||||||
| 41.2 | +16.52% | 10 | ||||||
| Average | 1,013.95 | +13.64% | 21 | ||||||
| Weighted average by Cap. | 702.8 | +9.27% | 24 |
- Stock Market
- Stocks
- AZN Stock
- Sector AstraZeneca PLC
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
